1. Home
  2. Search

Search

Search results

448 results found

David S. Friedman, MD, PhD, MPH

Person: Professor of Ophthalmology
Research Area(s): Glaucoma Harvard Medical School Co-Director, Glaucoma Center of Excellence Mass. Eye and Ear Director, Glaucoma ServiceAlbert and Diane Kaneb Chair in Ophthalmology Profiles: Harvard Catalyst Profile Mass. Eye and Ear Profile (Research) Mass. Eye and Ear Profile (Clinical)

Two Common Oculoplastics Disorders

Page
Primary Acquired Nasolacrimal Duct Obstruction (PANDO) PANDO is a condition in which chronic inflammation and scarring block the tear drainage system without another identifiable cause for the obstruction, such as trauma, tumor, etc. Patients with PANDO usually seek help when tears overflow...

eye Insights Issue 10: Idiopathic Intracranial Hypertension

Page
In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). You'll find key information about how IIH is diagnosed and treated. Inside: Message from the Editor-in-Chief What is Idiopathic Intracranial Hypertension? How is a Patient Diagnosed? What are the...

Message from the Editor-in-Chief

Page
Dear Colleagues, In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). Inside, you’ll find key information about how IIH is diagnosed and treated as well as further reading. IIH is becoming more prevalent due to increasing rates of obesity in the United...

What are the Treatment Options?

Page
Acetazolamide The first-line medical therapy is acetazolamide, which reduces CSF production by the choroid plexus. In the recent IIH Treatment Trial, acetazolamide, in addition to weight loss, was found to be more effective than weight loss alone in patients with IIH and mild visual loss. The...

Don't Let Glaucoma Rob Your Patients of Vision

Page
Nearly half of Americans who currently have glaucoma are unaware of their condition. Why? Most types of glaucoma are painless, with no feelings of discomfort. Glaucoma typically affects peripheral vision first, so many people remain unaware of the disease until their central vision is affected...

Mass. Eye and Ear Research Team Link Immune Cells to Uveitis

News: April 30, 2019
New research led by Kip Connor, PhD, finds that microglia—the primary immune cells of the central nervous system, including the retina—play a vital role in regulating neuroinflammation in autoimmune uveitis. The study, published in Proceedings of the National Academy of Sciences and featured on...

Highlights from the 2019 ARVO Annual Meeting

News: May 07, 2019
The Department of Ophthalmology was well represented at this year’s Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, held April 22 through May 2 in Vancouver, British Columbia. More than 160 faculty and trainees participated as course instructors, panelists, lecturers and...

2019 Trainee Graduation

News: June 28, 2019
Thirty-two Harvard Ophthalmology/Mass. Eye and Ear clinical trainees graduated on Thursday, June 20th. The ceremony celebrated eight Harvard Ophthalmology residents, the AY 2018–2019 Chief Resident and one optometry resident, as well as 22 clinical fellows from Mass. Eye and Ear, Joslin Diabetes...

Resident Noam Rudnick Receives Gragoudas-Folkman Award

News: August 08, 2019
Second-year Harvard Ophthalmology resident Noam Rudnick, MD, PhD, received the 2019 Gragoudas-Folkman Award, which will provide up to $20,000 to help fund his research on cell type-specific roles of autophagy in age-related macular degeneration. He will complete the project under the guidance of his...